BSEBoard MeetingResults1d ago
A D S Diagnostics Ltd
A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 12th November, 2026
A D S Diagnostics Ltd has scheduled a Board Meeting on 12th November, 2026 to consider unaudited financial results for the quarter ended 30th September, 2026.
BSEAGM/EGMResults1 Oct 2026
A D S Diagnostics Ltd
The voting Results as format prescribed under Regulation 44(3) of SEBI(LODR) Regulations, 2015 along with Scrutiniser Report on remote e- voting, are attached
A D S Diagnostics Ltd has announced the voting results of its 41st Annual General Meeting, with all resolutions passed with majority by the members. The company has attached the scrutinizer's report and voting results as per the SEBI (LODR) Regulations, 2015.
BSEAGM/EGMResults29 Sept 2026
A D S Diagnostics Ltd
List of Proceedings of Annual General Meeting of the Company held today i.e. September 29, 2026 is attached.
A D S Diagnostics Ltd held its 41st Annual General Meeting on September 29, 2026, through video conferencing. The meeting adopted the audited balance sheet and profit and loss statement for the year ended March 31, 2026. Resolutions were passed for the re-appointment of a director, declaration of dividend for the financial year 2025-26, ratification of the appointment of statutory auditors, and re-appointment of an independent director.
BSECompany UpdateDividend22 Sept 2026
A D S Diagnostics Ltd
Pursuant to regulation 42 of SEBI please find enclosed the date of record date for determining the record date for payment of divided to shareholders and date of book closure and determining the date for e-voting for AGM also the date for closing the register of members and share transfer books of the company.
A D S Diagnostics Ltd has announced the record date for determining dividend payment to shareholders and the book closure for the 41st Annual General Meeting. The company has recommended a final dividend of Rs 1.20 per equity share of Rs.10/- each (12%) for the financial year ended 31st March,2026.
BSEOthersResults4 Sept 2026
A D S Diagnostics Ltd
NOTICE IS HEREBY GIVEN that the 41st Annual General Meeting of the Members of ADS Diagnostic Limited will be held on Tuesday, the 29th September, 2026, at 11:30 A.M. Through Video Conferencing ....
ADS Diagnostics Ltd has announced its 41st Annual General Meeting (AGM) to be held on September 29, 2026, through video conferencing. The AGM will consider the audited financial statements for FY 2025-26, re-appointment of a director, and declaration of dividend.
BSEBoard MeetingResults13 Aug 2026
A D S Diagnostics Ltd
Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform ....
A D S Diagnostics Ltd has announced its unaudited standalone financial results for the quarter ended June 30, 2026. The company's income from operations was Rs. 328.21 lakhs, with other income at Rs. 23.33 lakhs. Total income was Rs. 351.54 lakhs. Expenses were Rs. 347.51 lakhs, resulting in a profit before tax of Rs. 4.03 lakhs. Tax expenses were Rs. 0.81 lakhs, leaving a net profit after tax of Rs. 3.22 lakhs. The company's EPS was Rs. 0.15.
BSEBoard MeetingResults4 Aug 2026
A D S Diagnostics Ltd
A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve The meeting of the Board ....
A D S Diagnostics Ltd has scheduled a board meeting on 13th August 2026 to consider and approve audited financial results for the quarter ended 30th June 2026.